GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeneTether Therapeutics Inc (XCNQ:GTTX) » Definitions » Net Change in Cash

GeneTether Therapeutics (XCNQ:GTTX) Net Change in Cash : C$-0.54 Mil (TTM As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is GeneTether Therapeutics Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

GeneTether Therapeutics's Net Change in Cash for the three months ended in Sep. 2024 was C$-0.09 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2024 was C$-0.54 Mil.


GeneTether Therapeutics Net Change in Cash Historical Data

The historical data trend for GeneTether Therapeutics's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GeneTether Therapeutics Net Change in Cash Chart

GeneTether Therapeutics Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Net Change in Cash
0.05 0.17 2.19 -0.58

GeneTether Therapeutics Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.10 - -0.15 -0.30 -0.09

GeneTether Therapeutics Net Change in Cash Calculation

GeneTether Therapeutics's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

GeneTether Therapeutics's Net Change in Cash for the quarter that ended in Sep. 2024


Net Change in Cash for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.54 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


GeneTether Therapeutics Net Change in Cash Related Terms

Thank you for viewing the detailed overview of GeneTether Therapeutics's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.


GeneTether Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
301-1665 Ellis Street, c/o Pushor Mitchell LLP, Kelowna, BC, CAN, X1X 1X1
GeneTether Therapeutics Inc is a genetic medicines company focused on the development of high-efficiency precision gene editing for human therapeutics applications. It is engaged in creating gene-editing therapies based on the proprietary GeneTether platform. Further, it is focused on building a discovery pipeline for the treatment of rare, monogenic diseases of the kidney and the skin. Their platform is designed to increase the efficiency of genome editing technologies, including CRISPR-Cas, TALENs, and ZFNs.

GeneTether Therapeutics Headlines

No Headlines